Click to view this email in a browser
Forward this message to a colleague
Join Us for a Series of Expert Connections Webinars
GBCHealth’s Expert Connections series gives its members access to leading business and global health leaders as well as insights into the latest advances and developments in global health. GBCHealth has launched three new three-part series on HIV/AIDS, on diabetes and on our annual Business Action on Health Awards.
On August 30 you can get a jump start on your 2013 awards application with advice from the 2012 winners, who will detail their approaches, challenges and lessons learned. The diabetes series kicks off September 13 with a panel on Diabetes 101: The Global Face of the Epidemic. Speakers from the CDC, Global Diabetes Initiative at the Albert Einstein College of Medicine and the National Institute of Diabetes and Digestive and Kidney Disease will provide updates on diabetes in emerging markets, including China, India, Latin America and the Caribbean, along with a look at global partnerships addressing the disease.
July 21, 2012 | Washington, D.C.
On the eve of the XIX International AIDS Conference in Washington, D.C., GBCHealth, in partnership with amfAR, hosted a dinner at the Kennedy Center. Visionary businessman and philanthropist Bill Gates accepted amfAR’s Award of Courage, saying, “We have many potential game-changers that are bringing us closer to the end of AIDS." More than 20 GBCHealth member companies attended, as well as entertainers and political leaders who included Minority Leader Nancy Pelosi, Congresswoman Barbara Lee of California, Congressman Ed Markey of Massachusetts, Secretary of Health and Human Services Kathleen Sebelius, actress Sharon Stone, newscaster Anderson Cooper and legendary American soprano Jessye Norman. GBCHealth’s outgoing President and CEO John Tedstrom delivered moving remarks highlighting the essential role of the private sector in driving progress on AIDS.
Help GBCHealth Reach 100 Signatories by World AIDS Day 2012
GBCHealth, in partnership with UNAIDS and member Levi Strauss & Co., is working to help lift travel restrictions against people living with HIV/AIDS through a CEO pledge demonstrating private sector commitment to ending these practices. These travel restrictions, still in existence in 45 countries, are discriminatory and harm business, restricting employees from traveling or migrating for work. Already 26 leading CEOs have demonstrated their leadership on this issue and have signed the pledge, and some have blogged, tweeted and promoted the pledge on their company Web sites. The goal is to garner 100 CEO signatures by World AIDS Day 2012 on December 1, which will feature a large promotion on the pledge.
Officially announced at the Together to End AIDS Gala in Washington, D.C. on July 21, Levi Strauss & Co.’s Helga Ying spoke the next morning at a UNAIDS session on HIV travel restrictions at the International AIDS Conference, where South Korea announced it was lifting its travel restrictions. The CEO pledge was covered widely in the media, including International Business News, Voice of America and Agence France Presse. Since the launch, two new companies have joined, Pfizer and FSG.
Fast Forward on Sustainability at the BSR Annual Conference
October 23-26, 2012 | New York, NY
GBCHealth member BSR hosts its annual conference in New York City from October 23-26. Themed “Fast Forward,” this year’s conference promises to provide a fascinating exploration of new thinking and approaches for building sustainable practices into your business. Bringing together 1,000 leaders from business, civil society, and the public sector, the annual BSR Conference is one of the world’s largest and most influential events devoted to sustainable business. The BSR conference starts the day after GBCHealth and Massachusetts General Hospital host a half-day symposium on Technology Innovations for Maternal & Child Health (free to members). Consider combining both events! Learn more about the BSR Conference...
Mylan Signs Agreement with Gilead to Accelerate Access to HIV Medicines
Mylan Inc. has signed a licensing agreement with Gilead Sciences, Inc. to produce and market generic versions of Gilead’s HIV/AIDS medicines containing emtricitabine.
Mylan and Gilead are both members of the Private Sector Delegation (PSD) to the Global Fund, a group of companies that participate in governance and policy for the Global Fund to Fight AIDS, Tuberculosis and Malaria. The PSD is facilitated by GBCHealth.
Gilead has entered into agreements with Mylan and two other Indian pharmaceutical companies to improve access to low-cost generic versions of Gilead’s HIV medicines in developing countries.
The library is its richest resource. Check it out!
In last year’s GBCHealth member survey, many of you told us that you valued the rich content and information- sharing opportunities on GBCHealth.org. But some respondents were unfamiliar with the site’s riches. Take a peek at two great features on our site, both created with GBCHealth members in mind: the Content Library and Member News areas.
GBCHealth's Content Library houses a comprehensive collection of tools, resources, case studies and event recaps related to business action on global health. The library features both GBCHealth-created materials as well as resources developed by members and key partners. Many of these resources are “Members Only,” so be sure to sign in or request access when prompted. Our Member News section highlights the latest actions of member companies and organizations, including new programs and partnerships.
GBCHealth Members Help AIDS Response in China
July 27, 2012 | Beijing, China
GBCHealth China, in collaboration with member companies BD, Standard Chartered Bank, Sohu, Hub One International, Merck and Anglo American, launched the CD4 equipment donation project on July 27 in Beijing. The project aims to provide much needed CD4 testing equipment, which measures how far along HIV has progressed in the body, to Lianghsan, in the Sichuan province, which is hard hit by the HIV/AIDS epidemic. The equipment will enable the local government in this rural region to provide timely treatment and care.
BD China donated three sets of CD4 equipment, valued at over US$ 200,000. Other companies will contribute to the project in their areas of core competence:
The launch also contributed to awareness building around AIDS in China, with more than 15 major media outlets covering the event.
GBCHealth Members Contribute to Summer Camp for AIDS Impacted Youth in China
July 16-25, 2012 | Beijing, China
GBCHealth and the Chi Heng Foundation hosted the seventh annual camp for AIDS-impacted youth in Bejing, with 40 teens 14-16 years old from poverty stricken areas attended the five-day summer camp. Corporate participation in the program demonstrates leadership and helps reduce stigma against those infected and affected by AIDS. This year GBCHealth members Anglo American, BD, The Coca-Cola Company, Standard Chartered Bank and Waggner Edstrom supported the program, which included visits to Standard Chartered Bank and Waggner Edstrom.
By Eve Heyn, Manager, Communications & External Affairs, GBCHealth
In a recent New Yorker article, staff writer Michael Specter travels to Brazil to see efforts underway to combat the deadly dengue virus with genetically modified mosquitoes. But while results so far are promising, the insects have sparked a fierce debate as opponents fear the deployment of “robo-Franken mosquitoes.”
Photo credits, from top to bottom: Brent Stirton/Getty Images for GBCHealth; Whitney Kidder for GBCHealth; WireImage; WireImage; jrodmanjr; Brent Stirton/Getty Images for GBCHealth; Brent Stirton/Getty Images for GBCHealth
New York, New York